APPLIED DNA SCIENCES, INC. Applied DNA Sciences, Inc. Stock
Equities
APDN
US03815U4094
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.652 USD | -67.24% |
|
-65.33% | -94.73% |
| 08:16pm | Top Midday Decliners | MT |
| 04:38pm | Applied DNA Sciences Prices $12 Million Public Offering of Units | MT |
Financials (USD)
| Sales 2024 * | 5.22M | Sales 2025 * | 7.39M | Capitalization | 9.89M |
|---|---|---|---|---|---|
| Net income 2024 * | -12M | Net income 2025 * | -13M | EV / Sales 2024 * | 1.89 x |
| Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.34 x |
| P/E ratio 2024 * |
-0.2
x | P/E ratio 2025 * |
-0.33
x | Employees | 54 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.1% |
More Fundamentals
* Assessed data
More news
Latest transcript on Applied DNA Sciences, Inc.
More recommendations
More press releases
More news
| 1 day | -67.24% | ||
| 1 week | -65.33% | ||
| Current month | -83.75% | ||
| 1 month | -83.12% | ||
| 3 months | -94.55% | ||
| 6 months | -96.38% | ||
| Current year | -94.73% |
1 week
0.57
2.24
1 month
0.574.75
Current year
0.5714.40
1 year
0.5737.20
3 years
0.57162.00
5 years
0.57536.00
10 years
0.577 760.00
| Managers | Title | Age | Since |
|---|---|---|---|
James Hayward
CEO | Chief Executive Officer | 71 | 05-09-27 |
Beth Jantzen
DFI | Director of Finance/CFO | 47 | 13-04-30 |
Lawrence Jung
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yacov Shamash
BRD | Director/Board Member | 74 | 06-03-16 |
Bob Catell
BRD | Director/Board Member | 87 | 16-10-06 |
James Hayward
CEO | Chief Executive Officer | 71 | 05-09-27 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-28 | 0.6451 | -67.58% | 9 639 832 |
| 24-05-24 | 1.99 | -1.97% | 81,088 |
| 24-05-23 | 2.03 | +4.18% | 194,131 |
| 24-05-22 | 1.948 | +3.92% | 94,979 |
| 24-05-21 | 1.875 | -4.34% | 146,077 |
Delayed Quote Nasdaq, May 28, 2024 at 02:46 pm EDT
More quotes
Applied DNA Sciences, Inc. is a biotechnology company that develops, and markets deoxyribonucleic acid (DNA) based technology solutions. The Company is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Companyâs proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting and anti-theft technology purposes. It also develops PCR-based molecular in vitro diagnostics for covid-19. In addition, under its wholly owned subsidiary, Applied DNA Clinical Labs, LLC, the Company is offering a high-throughput turnkey solution for population-scale Covid-19 testing marketed as safeCircle. safeCircle utilizes the Companyâs Covid-19 Diagnostic Tests and is designed to look for infection within defined populations or communities utilizing high throughput testing methodologies.
Calendar
2024-06-11
- Investor Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
1.99
USD
Average target price
30
USD
Spread / Average Target
+1,407.54%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -94.73% | 9.89M | |
| -6.41% | 12.2B | |
| -4.07% | 8.22B | |
| +5.77% | 5.72B | |
| +27.68% | 5.42B | |
| -59.63% | 2.7B | |
| +8.04% | 2.63B | |
| -6.47% | 2.38B | |
| +22.36% | 2.1B | |
| -8.15% | 1.81B |
- Stock Market
- Equities
- APDN Stock
